Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUKOCYTE IG-LIKE RECEPTOR A4) (HUMAN MONOCLONAL VIB7734 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIB7734 .LAMBDA.-CHAIN, DIMER

Sjogren's Syndrome

Amgenmonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Sjogren's Syndrome cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Peking Union Medical College Hospital
Phase 4BB
Belimumab
Peking Union Medical College Hospital
Phase 4B
Diluent
Instituto de Oftalmología Fundación Conde de Valenciana
Phase 3B
Bcma-Cd19 Ccar T Cells
Peking University People's Hospital
Phase 2CCC
Car-Nk Cell
Bangdong Gong
Phase 1/2CCC

View all 11 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUKOCYTE IG-LIKE RECEPTOR A4) (HUMAN MONOCLONAL VIB7734 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIB7734 .LAMBDA.-CHAIN, DIMER is also rated in:

cutaneous lupus erythematosusDormant
CC
Indicative ·
47 / 100
View asset →
systemic sclerosisDormant
CC
Indicative ·
47 / 100
View asset →
polymyositisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →